Remove Echocardiogram Remove Innovation Remove Ultrasound
article thumbnail

UltraSight Expands Access to Cardiac Monitoring with AI

DAIC

11, 2025 UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound,recentlyannounced support from Bristol Myers Squibb (BMS) for a study that aims to improve access to echocardiographic assessments for patients with obstructive hypertrophic cardiomyopathy (oHCM). tim.hodson Tue, 02/18/2025 - 16:17 Feb.

article thumbnail

Ultromics Announces Partnership to Expedite Development of Echo AI Algorithm for Early Detection of Cardiac Amyloidosis

DAIC

The algorithm uses deep learning to analyse routine ultrasound scans of the heart ( echocardiograms ) to detect disease that often goes undetected during standard assessments. For more information: [link] References: 1 Maurer M, Elliott P, Comenzo R, et al.

article thumbnail

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

DAIC

To this end, ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services.

article thumbnail

Novel AI Platform Matches Cardiologists in Detecting Rheumatic Heart Disease

DAIC

Developed at Children’s National Hospital and detailed in the latest edition of the Journal of the American Heart Association , the new AI system combines the power of novel ultrasound probes with portable electronic devices installed with algorithms capable of diagnosing RHD on echocardiogram.

article thumbnail

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

Before the procedure, patients should have an electrocardiogram (ECG) and echocardiogram (ultrasound of the heart) to check the heart’s rhythm and function. Some patients need computed tomography or transoesophageal echocardiography to exclude the presence of a blood clot in the heart. The risk of death is extremely low (0.05-0.1%).